- Home
- ORKA vs AVAH Comparison
ORKA vs AVAH Comparison
Compare ORKA & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- AVAH
- Stock Information
- Founded
- ORKA 2004
- AVAH 1984
- Country
- ORKA United States
- AVAH United States
- Employees
- ORKA N/A
- AVAH N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AVAH Hospital/Nursing Management
- Sector
- ORKA Health Care
- AVAH Health Care
- Exchange
- ORKA Nasdaq
- AVAH Nasdaq
- Market Cap
- ORKA 1.0B
- AVAH 1.1B
- IPO Year
- ORKA N/A
- AVAH 2021
- Fundamental
- Price
- ORKA $19.76
- AVAH $4.51
- Analyst Decision
- ORKA Strong Buy
- AVAH Hold
- Analyst Count
- ORKA 6
- AVAH 3
- Target Price
- ORKA $43.60
- AVAH $4.27
- AVG Volume (30 Days)
- ORKA 396.0K
- AVAH 241.1K
- Earning Date
- ORKA 02-15-2025
- AVAH 11-07-2024
- Dividend Yield
- ORKA N/A
- AVAH N/A
- EPS Growth
- ORKA N/A
- AVAH N/A
- EPS
- ORKA N/A
- AVAH N/A
- Revenue
- ORKA N/A
- AVAH $1,983,475,000.00
- Revenue This Year
- ORKA N/A
- AVAH $7.85
- Revenue Next Year
- ORKA N/A
- AVAH $5.09
- P/E Ratio
- ORKA N/A
- AVAH N/A
- Revenue Growth
- ORKA N/A
- AVAH 6.21
- 52 Week Low
- ORKA $17.64
- AVAH $2.00
- 52 Week High
- ORKA $53.88
- AVAH $6.19
- Technical
- Relative Strength Index (RSI)
- ORKA N/A
- AVAH 42.27
- Support Level
- ORKA N/A
- AVAH $4.37
- Resistance Level
- ORKA N/A
- AVAH $4.75
- Average True Range (ATR)
- ORKA 0.00
- AVAH 0.28
- MACD
- ORKA 0.00
- AVAH -0.01
- Stochastic Oscillator
- ORKA 0.00
- AVAH 38.79
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.
About AVAH Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is primarily derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.